Larvol Delta - Circle-Pharmas-FirstinClass-Oral-Macrocycle-Cyclin-AB-RxL-Inhibitor-CID078-Preclinical-Data-Highlighted-at-the-36th-EORTCNCIAACR-Symposium

CID-078 - Circle Pharma

https://www.businesswire.com/news/home/20241023130729/en/Circle-Pharma%E2%80%99s-First-in-Class-Oral-Macrocycle-Cyclin-AB-RxL-Inhibitor-CID-078-Preclinical-Data-Highlighted-at-the-36th-EORTC-NCI-AACR-Symposium

Oct 23, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next